A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults
Clinical trial NCT07728396 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07728396
- Sponsor
- GC Biopharma Corp
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2027-05-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.